Search - tctmd.com

Displaying 981 - 1000 of 1334

Sort: Relevancy | Date

Presentation

Bivalirudin vs. Heparin Plus a GPI in Pts with NSTEMI Undergoing PCI After Clopidogrel Pretreatment

Presenter: G. Ndrepepa

October 18, 2012

News Daily News

Un Informe del Registro CathPCI Detalla los Patrones Contemporáneos de Práctica Clínica en EE.UU.

Caitlin E. Cox

October 18, 2012

News Daily News

Un Estudio Avala ½ Dosis de Prasugrel en Pacientes de Poco Peso con EAC

October 18, 2012

News Daily News

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

October 18, 2012

News Daily News

CathPCI Registry Report Details Contemporary US Practice Patterns

Caitlin E. Cox

October 18, 2012

News Daily News

Subestudio FAME: La PCI guiada por FFR es igual para Mujeres y Hombres

October 17, 2012

News Daily News

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

October 17, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

October 12, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

Subestudio PLATO: El Ticagrelor se asocia a Menos Hemorragias, Infecciones y Muerte que el Clopidogrel tras CABG

September 27, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

Presentation

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presenter: Christoph Varenhorst

September 26, 2012

News Daily News

Son Muchos los Factores que Contribuyeron a los ACV Perioperatorios del Ensayo SAMMPRIS

September 21, 2012

News Daily News

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

September 21, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Even When It Fails, Endovascular Therapy Better First-Line Treatment than Surgery for Aortoiliac Disease

L.A. McKeown

September 19, 2012

News Daily News

Aún Cuando Fracasa, la Terapia Endovascular es Mejor como Tratamiento de 1ª Línea que la Cirugía contra la Enfermedad Aortoilíaca

L.A. McKeown

September 19, 2012

Advertisement

Bivalirudin vs. Heparin Plus a GPI in Pts with NSTEMI Undergoing PCI After Clopidogrel Pretreatment

Un Informe del Registro CathPCI Detalla los Patrones Contemporáneos de Práctica Clínica en EE.UU.

Un Estudio Avala ½ Dosis de Prasugrel en Pacientes de Poco Peso con EAC

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

CathPCI Registry Report Details Contemporary US Practice Patterns

Subestudio FAME: La PCI guiada por FFR es igual para Mujeres y Hombres

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Subestudio PLATO: El Ticagrelor se asocia a Menos Hemorragias, Infecciones y Muerte que el Clopidogrel tras CABG

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Son Muchos los Factores que Contribuyeron a los ACV Perioperatorios del Ensayo SAMMPRIS

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Even When It Fails, Endovascular Therapy Better First-Line Treatment than Surgery for Aortoiliac Disease

Aún Cuando Fracasa, la Terapia Endovascular es Mejor como Tratamiento de 1ª Línea que la Cirugía contra la Enfermedad Aortoilíaca

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content